Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-646

It's not hard to imagine that various self-test kits could become a standard part of the basic med stuff you have at home. for example, the one that tells you whether you have an viral or bacterial condition.i wouldn't be surprised if that turned out to be a big deal. although, of course, who really knows? new products appear, new breakthroughs are made, and everything changes. but i guess that is the nature of investing in individual companies, as opposed to funds and indexes etc.

speaking of funds, i wonder if AEF has invested in AT1.